Corcept Therapeutics (CORT)

$17.85 0.00 (0.00%)

16:12 EDT CORT Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 2.06B

PE Ratio 15.66

EPS 1.14

Volume (Avg. Vol.)

Day's Range 17.85 - 17.85

52-Week Range 9.70 - 23.48

Dividend & Yield N/A (N/A)

CORT Stock Predictions, Articles, and Corcept Therapeutics News

From InvestorPlace
From the Web

7 Great Biotech Stocks to Buy and Hold Now

By Chris Markoch Jun 11, 2020

As investors begin to turn their attention away from Covid-19 and the novel coronavirus, these biotech stocks present excellent opportunities.

FDA Shame List: 40 Drug Makers That Try to Block Generic Drugs

By Karl Utermohlen, InvestorPlace Writer May 18, 2018

The Food and Drug Administration (FDA) announced a list of drug makers that have tried to block generic drugs in its new shame list. Here they are.

10 Healthcare Stocks to Stave Off the Market Flu

By Louis Navellier, Editor, Growth Investor Apr 6, 2018

One thing is certain, healthcare isn’t going away.

Plains GP Holdings LP (PAGP) and Green Plains Inc (GPRE) Lead Today’s Top 11 Investor Filings

By Fintel Jun 15, 2017

13D and 13G filings are windows on activist investor activity. Today we focus on Plains GP Holdings LP, Green Plains Inc and 9 other filings

7 Healthcare Stocks With A-Rated Prospects

By Louis Navellier, Editor, Growth Investor Apr 21, 2017

An Obamacare replacement is back in the news, and these seven A-rated healthcare stocks are winners regardless of how it shakes out.

Pre-earnings Momentum Trade With a Technical Trigger in Corcept Therapeutics Inc

From Capital Market Laboratories Oct 23, 2020

The Techncial Trigger Driven Option Trade Right Before Corcept Therapeutics Inc (NASDAQ:CORT) Earnings.

Why Corcept Therapeutics Soared 37% Higher in September

From The Motley Fool Oct 7, 2020

A patent decision on its cortisol therapy Korlym is expected to be rendered next month.

Are These The Top Pharmaceutical Stocks To Buy In October 2020?

From StockMarket.com Oct 1, 2020

Looking for long-term buys for your portfolio? Take a look at these 3 top pharmaceutical stocks.

First Week of CORT May 2021 Options Trading

From Market News Video Sep 18, 2020

Investors in Corcept Therapeutics Inc (CORT) saw new options begin trading this week, for the May 2021 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 245 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

Corcept's Lead Drug Korlym Aids Growth, Heavy Reliance a Woe

From Zacks Investment Research Sep 17, 2020

Corcept's (CORT) Cushing's syndrome drug Korlym shows a steady progress. Other pipeline candidates are advancing as well. However, heavy dependence on Korlym for growth remains an overhang.

January 2023 Options Now Available For Corcept Therapeutics (CORT)

From Market News Video Sep 14, 2020

Investors in Corcept Therapeutics Inc (CORT) saw new options begin trading today, for the January 2023 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 858 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

Navellier Ratings

Powered by Portfolio Grader

Total Grade

B

Buy